Quick answers
- What is Glyburide used for?
- The FDA-approved label (Glyburide, TEVA Pharmaceuticals USA Inc, July 1, 2021) says: “Glyburide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Glyburide have a boxed warning?
- No. None of the 36 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Glyburide?
- The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated August 10, 2026). Ask your pharmacist about alternatives.
- Has Glyburide been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Glyburide?
- 15 companies list prescription products of Glyburide in the FDA NDC Directory, including NuCare Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and A-S Medication Solutions.
What Glyburide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Glyburide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
— FDA label: Glyburide, TEVA Pharmaceuticals USA Inc, effective July 1, 2021. Read the full label on DailyMed →
The FDA has 36 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 36 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 54 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| glyburide 1.25 mg tablet | Generic | $0.0605 per tablet |
| glyburide 2.5 mg tablet | Generic | $0.0646 per tablet |
| glyburide 3 mg tablet | Generic | $0.1281 per tablet |
| glyburide 5 mg tablet | Generic | $0.0683 per tablet |
| glyburide 6 mg tablet | Generic | $0.2394 per tablet |
NADAC list of November 4, 2026; these prices took effect between April 22, 2026 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- NuCare Pharmaceuticals, Inc.8 products
- Teva Pharmaceuticals USA, Inc.8 products
- A-S Medication Solutions6 products
- Proficient Rx LP4 products
- Zydus Lifesciences Limited3 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.3 products
- Cadila Pharmaceuticals Limited3 products
- Zydus Pharmaceuticals USA Inc.3 products
- Chartwell RX, LLC3 products
- Bryant Ranch Prepack3 products
- Modavar Pharmaceuticals LLC3 products
- Preferred Pharmaceuticals Inc.2 products
- Remedyrepack Inc.2 products
- Northwind Health Company, LLC2 products
- Coupler LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA017532 DIABETA | Sanofi Aventis Us | May 1, 1984 | 30, latest January 11, 2017 2017: Labeling · 2014: Manufacturing (CMC) · 2013: Labeling |
Generic approvals (5)
- ANDA074388Teva · August 29, 1995
- ANDA074686Teva · April 20, 1999
- ANDA090937Heritage · February 28, 2011
- ANDA206749Zydus Pharms · May 10, 2016
- ANDA203379Cadila Pharms Ltd · January 4, 2019
Shortage status
To be discontinued · updated August 10, 2026 · first posted August 10, 2026
| Product | Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01) |
|---|---|
| Company | Sanofi-Aventis U.S. LLC |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Glyburide, TEVA Pharmaceuticals USA Inc, effective July 1, 2021; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →